CSBR:NASDAQ
Champions Oncology Inc
USD 4,59
arrow_downward
-1,89%(-0,088) 1D
17 Nov., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,70
High
USD 4,70
Low
USD 4,59
Mkt. cap
63,91 m
Avg. vol.
7,80 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,70
High
USD 4,70
Low
USD 4,59
Mkt. cap
63,91 m
Avg. vol.
7,80 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
MarketWatch
·
48 minute gelede
Stock Market Today: Dow, S&P 500 and Nasdaq set to climb as Nvidia shares rise after boosting guidance; Anthropic expected to price IPO: live updates
The Motley Fool
·
2 uur gelede
Vanguard S&P 500 ETF vs. Schwab U.S. Dividend ETF: How Much You’d Need to Collect $1,000 a Month From Each.
Trefis
·
6 uur gelede
S&P 500 Movers | Winners: FIX, COHR, CIEN | Losers: CRM, INTU, NOW
Fox Business
·
16 uur gelede
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com